Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by Candida albicans Hyphae.

Rogiers O, Frising UC, Kucharíková S, Jabra-Rizk MA, van Loo G, Van Dijck P, Wullaert A.

MBio. 2019 Jan 8;10(1). pii: e02221-18. doi: 10.1128/mBio.02221-18.

2.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

3.

Topical therapy for refractory rhinosinusitis caused by methicillin-resistant Staphylococcus aureus: First report in a prospective series.

Shikani AH, Khoueir N, Jabra-Rizk MA, Shikani HJ, Basaraba RJ, Leid JG.

Auris Nasus Larynx. 2018 Oct;45(5):994-999. doi: 10.1016/j.anl.2018.01.009. Epub 2018 Feb 6.

PMID:
29426723
4.

The oral microbiome: A Lesson in coexistence.

Sultan AS, Kong EF, Rizk AM, Jabra-Rizk MA.

PLoS Pathog. 2018 Jan 25;14(1):e1006719. doi: 10.1371/journal.ppat.1006719. eCollection 2018 Jan. Review. No abstract available.

5.

Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.

Ikonomova SP, Moghaddam-Taaheri P, Jabra-Rizk MA, Wang Y, Karlsson AJ.

FEBS J. 2018 Jan;285(1):146-159. doi: 10.1111/febs.14327. Epub 2017 Nov 29.

6.

Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.

Kong EF, Tsui C, Kucharíková S, Van Dijck P, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01573-17. doi: 10.1128/AAC.01573-17. Print 2017 Dec.

7.

Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix.

Kong EF, Tsui C, Kucharíková S, Andes D, Van Dijck P, Jabra-Rizk MA.

MBio. 2016 Oct 11;7(5). pii: e01365-16. doi: 10.1128/mBio.01365-16.

8.

Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us.

Kong EF, Johnson JK, Jabra-Rizk MA.

PLoS Pathog. 2016 Oct 6;12(10):e1005837. doi: 10.1371/journal.ppat.1005837. eCollection 2016 Oct. Review. No abstract available.

9.

Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M.

Infect Immun. 2016 Sep 19;84(10):2724-39. doi: 10.1128/IAI.00469-16. Print 2016 Oct. Review.

10.

Candida albicans in oral biofilms could prevent caries.

Willems HM, Kos K, Jabra-Rizk MA, Krom BP.

Pathog Dis. 2016 Jul;74(5). pii: ftw039. doi: 10.1093/femspd/ftw039. Epub 2016 Apr 28.

PMID:
27129365
11.

Pathogenesis of Candida albicans biofilm.

Tsui C, Kong EF, Jabra-Rizk MA.

Pathog Dis. 2016 Jun;74(4):ftw018. Review.

12.

Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Kong EF, Tsui C, Boyce H, Ibrahim A, Hoag SW, Karlsson AJ, Meiller TF, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):881-9. doi: 10.1128/AAC.02624-15. Print 2016 Feb.

13.

Adherence of Streptococcus mutans on lithium disilicate porcelain specimens.

Vo DT, Arola D, Romberg E, Driscoll CF, Jabra-Rizk MA, Masri R.

J Prosthet Dent. 2015 Nov;114(5):696-701. doi: 10.1016/j.prosdent.2015.06.017. Epub 2015 Sep 16.

PMID:
26384535
14.

Periodontal Diseases: Bug Induced, Host Promoted.

Khan SA, Kong EF, Meiller TF, Jabra-Rizk MA.

PLoS Pathog. 2015 Jul 30;11(7):e1004952. doi: 10.1371/journal.ppat.1004952. eCollection 2015 Jul. Review. No abstract available.

15.

The great escape: pathogen versus host.

Kong E, Jabra-Rizk MA.

PLoS Pathog. 2015 Mar 12;11(3):e1004661. doi: 10.1371/journal.ppat.1004661. eCollection 2015 Mar. Review. No abstract available.

16.

Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.

Kong EF, Kucharíková S, Van Dijck P, Peters BM, Shirtliff ME, Jabra-Rizk MA.

Infect Immun. 2015 Feb;83(2):604-13. doi: 10.1128/IAI.02843-14. Epub 2014 Nov 24.

17.

Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue.

Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hänsch GM, Filler SG, Jabra-Rizk MA, Shirtliff ME.

Microbiology. 2015 Jan;161(Pt 1):168-181. doi: 10.1099/mic.0.083485-0. Epub 2014 Oct 20.

18.

In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.

Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2015 Feb;70(2):470-8. doi: 10.1093/jac/dku374. Epub 2014 Oct 6.

19.

Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms.

Demuyser L, Jabra-Rizk MA, Van Dijck P.

Pathog Dis. 2014 Apr;70(3):219-30. doi: 10.1111/2049-632X.12123. Epub 2014 Jan 27. Review.

PMID:
24376219
20.

Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation.

Metwalli KH, Khan SA, Krom BP, Jabra-Rizk MA.

PLoS Pathog. 2013;9(10):e1003616. doi: 10.1371/journal.ppat.1003616. Epub 2013 Oct 17. Review. No abstract available.

21.

Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.

Khan SA, Fidel PL Jr, Thunayyan AA, Varlotta S, Meiller TF, Jabra-Rizk MA.

J AIDS Clin Res. 2013 Mar 5;4(193). pii: 1000193.

22.

Draft Genome Sequence of the Methicillin-Resistant Staphylococcus aureus Isolate MRSA-M2.

Harro JM, Daugherty S, Bruno VM, Jabra-Rizk MA, Rasko DA, Shirtliff ME.

Genome Announc. 2013 Jan;1(1). pii: e00037-12. doi: 10.1128/genomeA.00037-12. Epub 2013 Jan 31.

23.

Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p.

Peters BM, Ovchinnikova ES, Krom BP, Schlecht LM, Zhou H, Hoyer LL, Busscher HJ, van der Mei HC, Jabra-Rizk MA, Shirtliff ME.

Microbiology. 2012 Dec;158(Pt 12):2975-2986. doi: 10.1099/mic.0.062109-0. Epub 2012 Aug 23.

24.

Polymicrobial interactions: impact on pathogenesis and human disease.

Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME.

Clin Microbiol Rev. 2012 Jan;25(1):193-213. doi: 10.1128/CMR.00013-11. Review.

25.

Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione.

Zhu J, Krom BP, Sanglard D, Intapa C, Dawson CC, Peters BM, Shirtliff ME, Jabra-Rizk MA.

PLoS One. 2011;6(12):e28830. doi: 10.1371/journal.pone.0028830. Epub 2011 Dec 19.

26.

"Persisters": survival at the cellular level.

Dawson CC, Intapa C, Jabra-Rizk MA.

PLoS Pathog. 2011 Jul;7(7):e1002121. doi: 10.1371/journal.ppat.1002121. Epub 2011 Jul 28. Review. No abstract available.

27.

Antimicrobial peptides: primeval molecules or future drugs?

Peters BM, Shirtliff ME, Jabra-Rizk MA.

PLoS Pathog. 2010 Oct 28;6(10):e1001067. doi: 10.1371/journal.ppat.1001067. Review. No abstract available.

28.

Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms.

Peters BM, Jabra-Rizk MA, Scheper MA, Leid JG, Costerton JW, Shirtliff ME.

FEMS Immunol Med Microbiol. 2010 Aug;59(3):493-503. doi: 10.1111/j.1574-695X.2010.00710.x. Epub 2010 Jun 7.

29.

Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection.

Peters BM, Zhu J, Fidel PL Jr, Scheper MA, Hackett W, El Shaye S, Jabra-Rizk MA.

FEMS Yeast Res. 2010 Aug 1;10(5):597-604. doi: 10.1111/j.1567-1364.2010.00632.x. Epub 2010 Apr 13.

30.

Cross-kingdom interactions: Candida albicans and bacteria.

Shirtliff ME, Peters BM, Jabra-Rizk MA.

FEMS Microbiol Lett. 2009 Oct;299(1):1-8. doi: 10.1111/j.1574-6968.2009.01668.x. Epub 2009 Jun 3. Review.

31.

Farnesol-induced apoptosis in Candida albicans.

Shirtliff ME, Krom BP, Meijering RA, Peters BM, Zhu J, Scheper MA, Harris ML, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2009 Jun;53(6):2392-401. doi: 10.1128/AAC.01551-08. Epub 2009 Apr 13.

32.

A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.

Meiller TF, Hube B, Schild L, Shirtliff ME, Scheper MA, Winkler R, Ton A, Jabra-Rizk MA.

PLoS One. 2009;4(4):e5039. doi: 10.1371/journal.pone.0005039. Epub 2009 Apr 7.

33.

Salivary histatin-5 and oral fungal colonisation in HIV+ individuals.

Torres SR, Garzino-Demo A, Meiller TF, Meeks V, Jabra-Rizk MA.

Mycoses. 2009 Jan;52(1):11-5. doi: 10.1111/j.1439-0507.2008.01602.x. Epub 2008 Oct 18. Review.

PMID:
18983435
34.

Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells.

Scheper MA, Shirtliff ME, Meiller TF, Peters BM, Jabra-Rizk MA.

Neoplasia. 2008 Sep;10(9):954-63.

35.

Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation.

Jabra-Rizk MA, Falkler WA Jr, Merz WG, Kelley JI, Baqui AA, Meiller TF.

Rev Iberoam Micol. 1999 Dec;16(4):187-93.

36.

Prevalence of oral Candida species ina North American pediatric population.

Jabra-Rizk MA, Torres SR, Rambob I, Meiller TF, Grossman LK, Minah G.

J Clin Pediatr Dent. 2007 Summer;31(4):260-3.

PMID:
19161062
37.

Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.

Jabra-Rizk MA, Shirtliff M, James C, Meiller T.

FEMS Yeast Res. 2006 Nov;6(7):1063-73.

38.

Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, Venezia RA.

J Clin Microbiol. 2006 Sep;44(9):3381-3.

39.

8th ASM conference on Candida and candidiasis: molecular tools provide insights into host-pathogen interactions.

Moran GP, Jabra-Rizk MA.

Mycopathologia. 2006 Jul;162(1):17-24. No abstract available.

PMID:
16830187
40.

Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.

Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME.

Antimicrob Agents Chemother. 2006 Apr;50(4):1463-9.

41.

Prevalence of Candida dubliniensis fungemia at a large teaching hospital.

Jabra-Rizk MA, Johnson JK, Forrest G, Mankes K, Meiller TF, Venezia RA.

Clin Infect Dis. 2005 Oct 1;41(7):1064-7. Epub 2005 Aug 30.

PMID:
16142677
42.

Efficacy of Listerine Antiseptic in reducing viral contamination of saliva.

Meiller TF, Silva A, Ferreira SM, Jabra-Rizk MA, Kelley JI, DePaola LG.

J Clin Periodontol. 2005 Apr;32(4):341-6.

PMID:
15811049
43.

Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal epithelial cells.

Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AA, Kelley JI, Meiller TF.

Rev Iberoam Micol. 2001 Mar;18(1):17-22.

44.

Fungal biofilms and drug resistance.

Jabra-Rizk MA, Falkler WA, Meiller TF.

Emerg Infect Dis. 2004 Jan;10(1):14-9. Review.

45.

Fungal drug resistance, biofilms, and new antifungals.

Wynn RL, Jabra-Rizk MA, Meiller TF.

Gen Dent. 2003 Mar-Apr;51(2):94-8. Review. No abstract available.

PMID:
15055679
46.

The histidine kinases of Candida albicans: regulation of cell wall mannan biosynthesis.

Kruppa M, Jabra-Rizk MA, Meiller TF, Calderone R.

FEMS Yeast Res. 2004 Jan;4(4-5):409-16.

47.

Prevalence of yeast among children in Nigeria and the United States.

Jabra-Rizk MA, Falkler WA Jr, Enwonwu CO, Onwujekwe DI Jr, Merz WG, Meiller TF.

Oral Microbiol Immunol. 2001 Dec;16(6):383-5.

PMID:
11737663
48.

Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions.

Jabra-Rizk MA, Ferreira SM, Sabet M, Falkler WA, Merz WG, Meiller TF.

J Clin Microbiol. 2001 Dec;39(12):4520-2.

49.

In vitro effect of oral antiseptics on human immunodeficiency virus-1 and herpes simplex virus type 1.

Baqui AA, Kelley JI, Jabra-Rizk MA, Depaola LG, Falkler WA, Meiller TF.

J Clin Periodontol. 2001 Jul;28(7):610-6.

PMID:
11422581
50.

In vitro studies of the efficacy of antimicrobials against fungi.

Meiller TF, Kelley JI, Jabra-Rizk MA, Depaola LG, Baqui AA, Falkler WA Jr.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):663-70.

PMID:
11402279

Supplemental Content

Loading ...
Support Center